Literature DB >> 11487527

Absence of ligand-induced regulation of kinin receptor expression in the rabbit.

T Sabourin1, K Guay, S Houle, J Bouthillier, D R Bachvarov, A Adam, F Marceau.   

Abstract

The induction of B(1) receptors (B(1)Rs) and desensitization or down-regulation of B(2) receptors (B(2)Rs) as a consequence of the production of endogenous kinins has been termed the autoregulation hypothesis. The latter was investigated using two models based on the rabbit: kinin stimulation of cultured vascular smooth muscle cells (SMCs) and in vivo contact system activation (dextran sulphate intravenous injection, 2 mg kg(-1), 5 h). Rabbit aortic SMCs express a baseline population of B(1)Rs that was up-regulated upon interleukin-1beta treatment ([(3)H]-Lys-des-Arg(9)-BK binding or mRNA concentration evaluated by RT - PCR; 4 or 3 h, respectively). Treatment with B(1)R or B(2)R agonists failed to alter B(1)R expression under the same conditions. Despite consuming endogenous kininogen (assessed using the kinetics of immunoreactive kinin formation in the plasma exposed to glass beads ex vivo) and producing hypotension mediated by B(2)Rs in anaesthetized rabbits, dextran sulphate treatment failed to induce B(1)Rs in conscious animals (RT - PCR in several organs, aortic contractility). By contrast, lipopolysaccharide (LPS, 50 microg kg(-1), 5 h) was an effective B(1)R inducer (kidney, duodenum, aorta) but did not reduce kininogen reserve. We tested the alternate hypothesis that endogenous kinin participate in LPS induction of B(1)Rs. Kinin receptor antagonists (icatibant combined to B-9858, 50 microg kg(-1) of each) failed to prevent or reduce the effect of LPS on B(1)R expression. Dextran sulphate or LPS treatments did not persistently down-regulate vascular B(2)Rs (jugular vein contractility assessed ex vivo). The kinin receptor autoregulation hypothesis is not applicable to primary cell cultures derived from a tissue known to express B(1)Rs in a regulated manner (aorta). The activation of the endogenous kallikrein-kinin system is ineffective to induce B(1)Rs in vivo in an experimental time frame sufficient for B(1)R induction by LPS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11487527      PMCID: PMC1572864          DOI: 10.1038/sj.bjp.0704158

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  47 in total

1.  Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor.

Authors:  S Houle; J F Larrivée; M Bachvarova; J Bouthillier; D R Bachvarov; F Marceau
Journal:  Hypertension       Date:  2000-06       Impact factor: 10.190

2.  Endotoxin sensitization to kinin B(1) receptor agonist in a non-human primate model: haemodynamic and pro-inflammatory effects.

Authors:  D deBlois; R A Horlick
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

Review 3.  The molecular pathogenesis of endotoxic shock and organ failure.

Authors:  R Karima; S Matsumoto; H Higashi; K Matsushima
Journal:  Mol Med Today       Date:  1999-03

4.  Non-competitive pharmacological antagonism at the rabbit B(1) receptor.

Authors:  J F Larrivée; L Gera; S Houle; J Bouthillier; D R Bachvarov; J M Stewart; F Marceau
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

5.  Bradykinin B(2) receptor endocytosis, recycling, and down-regulation assessed using green fluorescent protein conjugates.

Authors:  D R Bachvarov; S Houle; M Bachvarova; J Bouthillier; A Adam; F Marceau
Journal:  J Pharmacol Exp Ther       Date:  2001-04       Impact factor: 4.030

6.  Endothelial kinin B(1)-receptors are induced by myocardial ischaemia-reperfusion in the rabbit.

Authors:  C Mazenot; L Loufrani; D Henrion; C Ribuot; W Muller-Esterl; D Godin-Ribuot
Journal:  J Physiol       Date:  2001-01-01       Impact factor: 5.182

7.  In vivo protein-DNA interactions at the kinin B(1) receptor gene promoter: no modification on interleukin-1 beta or lipopolysaccharide induction.

Authors:  M Angers; R Drouin; M Bachvarova; I Paradis; F Marceau; D R Bachvarov
Journal:  J Cell Biochem       Date:  2000-05       Impact factor: 4.429

8.  Effect of endogenous kinins, prostanoids, and NO on kinin B1 and B2 receptor expression in the rabbit.

Authors:  F Marceau; J F Larrivée; J Bouthillier; M Bachvarova; S Houle; D R Bachvarov
Journal:  Am J Physiol       Date:  1999-12

9.  Bradykinin B(1) receptor-mediated changes in renal hemodynamics during endotoxin-induced inflammation.

Authors:  Joost P Schanstra; Maria E Marin-Castaño; Françoise Praddaude; Ivan Tack; Jean-Louis Ader; Jean-Pierre Girolami; Jean-Loup Bascands; Benoit Jeunier
Journal:  J Am Soc Nephrol       Date:  2000-07       Impact factor: 10.121

10.  Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia.

Authors:  C Emanueli; A Minasi; A Zacheo; J Chao; L Chao; M B Salis; S Straino; M G Tozzi; R Smith; L Gaspa; G Bianchini; F Stillo; M C Capogrossi; P Madeddu
Journal:  Circulation       Date:  2001-01-02       Impact factor: 29.690

View more
  3 in total

1.  Characterization of kinin receptors in human cultured detrusor smooth muscle cells.

Authors:  F Bellucci; P Cucchi; P Santicioli; M Lazzeri; D Turini; S Meini
Journal:  Br J Pharmacol       Date:  2006-12-18       Impact factor: 8.739

2.  Bradykinin forming capacity of oversulfated chondroitin sulfate contaminated heparin in vitro.

Authors:  Albert Adam; Nicolas Montpas; David Keire; Anik Désormeaux; Nancy J Brown; François Marceau; Benjamin Westenberger
Journal:  Biomaterials       Date:  2010-04-27       Impact factor: 12.479

3.  The effect of electronegativity and angiotensin-converting enzyme inhibition on the kinin-forming capacity of polyacrylonitrile dialysis membranes.

Authors:  Anik Désormeaux; Marie Eve Moreau; Yves Lepage; Jacques Chanard; Albert Adam
Journal:  Biomaterials       Date:  2008-03       Impact factor: 12.479

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.